Gregory Oakes
Corporate Officer/Principal chez RELYPSA INC
Profil
Gregory Oakes is currently the President-North America at Relypsa, Inc. Prior to his current position, he served as the President, Chief Executive Officer & Director at Landos Biopharma, Inc. from 2022 to 2024.
He also worked as a Director at BioNJ, Inc. and as an Independent Director at Entero Therapeutics, Inc. from 2020 to 2022.
Before that, Gregory was the Vice President-Otezla at Amgen, Inc. from 2019 to 2020 and the Vice President & General Manager-US at Celgene Corp.
from 2017 to 2019.
He held the position of Head-North America at Sandoz, Inc. from 2015 to 2017.
Additionally, Gregory served as the Executive Vice President & President-North America at Vifor Pharma AG from 2020 to 2021.
He also held positions at Novartis Pharmaceuticals Corp.
and Schering-Plough sro.
Mr. Oakes holds an MBA from Clemson University and an undergraduate degree from Edinboro University of Pennsylvania.
Postes actifs de Gregory Oakes
| Sociétés | Poste | Début |
|---|---|---|
| RELYPSA INC | Corporate Officer/Principal | - |
Anciens postes connus de Gregory Oakes
| Sociétés | Poste | Fin |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Directeur Général | 23/05/2024 |
| ENTERO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/06/2022 |
| VIFOR PHARMA | Corporate Officer/Principal | 11/10/2021 |
| AMGEN INC. | Corporate Officer/Principal | 01/08/2020 |
| CELGENE | Corporate Officer/Principal | 01/12/2019 |
Formation de Gregory Oakes
| Edinboro University of Pennsylvania | Undergraduate Degree |
| Clemson University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ENTERO THERAPEUTICS, INC. | Health Technology |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| Schering-Plough sro | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland. | Health Technology |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
